ADC Therapeutics (ADCT) Other Working Capital Changes (2019 - 2026)
ADC Therapeutics has reported Other Working Capital Changes over the past 8 years, most recently at -$247000.0 for Q1 2026.
- Quarterly results put Other Working Capital Changes at -$247000.0 for Q1 2026, up 93.59% from a year ago — trailing twelve months through Mar 2026 was -$1.6 million (down 154.7% YoY), and the annual figure for FY2025 was -$5.2 million, down 453.58%.
- Other Working Capital Changes reached -$247000.0 in Q1 2026 per ADCT's latest filing, down from $215000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $8.6 million in Q4 2023 and bottomed at -$9.5 million in Q3 2025.
- Median Other Working Capital Changes over the past 5 years was -$777.0 (2022), compared with a mean of $211937.5.
- Peak annual rise in Other Working Capital Changes hit 1766971.17% in 2023, while the deepest fall reached 131429.63% in 2023.
- Over 5 years, Other Working Capital Changes stood at -$489.0 in 2022, then soared by 1766971.17% to $8.6 million in 2023, then crashed by 65.52% to $3.0 million in 2024, then tumbled by 92.78% to $215000.0 in 2025, then plummeted by 214.88% to -$247000.0 in 2026.
- Business Quant data shows Other Working Capital Changes for ADCT at -$247000.0 in Q1 2026, $215000.0 in Q4 2025, and -$9.5 million in Q3 2025.